51 related articles for article (PubMed ID: 16521150)
1. Proteomic analysis of acute myeloid leukemia: Identification of potential early biomarkers and therapeutic targets.
López-Pedrera C; Villalba JM; Siendones E; Barbarroja N; Gómez-Díaz C; Rodríguez-Ariza A; Buendía P; Torres A; Velasco F
Proteomics; 2006 Apr; 6 Suppl 1():S293-9. PubMed ID: 16521150
[TBL] [Abstract][Full Text] [Related]
2. Comparative proteome analysis of acute myeloid leukemia with and without maturation.
Luczak M; Kaźmierczak M; Handschuh L; Lewandowski K; Komarnicki M; Figlerowicz M
J Proteomics; 2012 Oct; 75(18):5734-48. PubMed ID: 22850270
[TBL] [Abstract][Full Text] [Related]
3. Perspectives of proteomics in acute myeloid leukemia.
Czibere A; Grall F; Aivado M
Expert Rev Anticancer Ther; 2006 Nov; 6(11):1663-75. PubMed ID: 17134369
[TBL] [Abstract][Full Text] [Related]
4. TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia.
Zhang W; Liu B; Wu S; Zhao L
Open Med (Wars); 2023; 18(1):20220602. PubMed ID: 37016705
[TBL] [Abstract][Full Text] [Related]
5. Proteomics: Concepts and applications in human medicine.
Al-Amrani S; Al-Jabri Z; Al-Zaabi A; Alshekaili J; Al-Khabori M
World J Biol Chem; 2021 Sep; 12(5):57-69. PubMed ID: 34630910
[TBL] [Abstract][Full Text] [Related]
6. Oxidative Stress and ROS-Mediated Signaling in Leukemia: Novel Promising Perspectives to Eradicate Chemoresistant Cells in Myeloid Leukemia.
Trombetti S; Cesaro E; Catapano R; Sessa R; Lo Bianco A; Izzo P; Grosso M
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671113
[TBL] [Abstract][Full Text] [Related]
7. Impact of Tissue Enolase 1 Protein Overexpression in Esophageal Cancer Progression.
Hoang AT; Vizio B; Chiusa L; Cimino A; Solerio D; Do NH; Pileci S; Camandona M; Bellone G
Int J Med Sci; 2021; 18(6):1406-1414. PubMed ID: 33628097
[TBL] [Abstract][Full Text] [Related]
8. The Role of Reactive Oxygen Species in Acute Myeloid Leukaemia.
Sillar JR; Germon ZP; DeIuliis GN; Dun MD
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795243
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane Modulates AQP8-Linked Redox Signalling in Leukemia Cells.
Prata C; Facchini C; Leoncini E; Lenzi M; Maraldi T; Angeloni C; Zambonin L; Hrelia S; Fiorentini D
Oxid Med Cell Longev; 2018; 2018():4125297. PubMed ID: 30581529
[TBL] [Abstract][Full Text] [Related]
10. A novel oncogenic role for urokinase receptor in leukemia cells: molecular sponge for oncosuppressor microRNAs.
Li Santi A; Gorrasi A; Alfieri M; Montuori N; Ragno P
Oncotarget; 2018 Jun; 9(45):27823-27834. PubMed ID: 29963240
[TBL] [Abstract][Full Text] [Related]
11. The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL.
Kampen KR; Sulima SO; Verbelen B; Girardi T; Vereecke S; Rinaldi G; Verbeeck J; Op de Beeck J; Uyttebroeck A; Meijerink JPP; Moorman AV; Harrison CJ; Spincemaille P; Cools J; Cassiman D; Fendt SM; Vermeersch P; De Keersmaecker K
Leukemia; 2019 Feb; 33(2):319-332. PubMed ID: 29930300
[TBL] [Abstract][Full Text] [Related]
12. Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners.
Cappello P; Curcio C; Mandili G; Roux C; Bulfamante S; Novelli F
Cancers (Basel); 2018 Feb; 10(2):. PubMed ID: 29462900
[TBL] [Abstract][Full Text] [Related]
13. Fumarate hydratase is a critical metabolic regulator of hematopoietic stem cell functions.
Guitart AV; Panagopoulou TI; Villacreces A; Vukovic M; Sepulveda C; Allen L; Carter RN; van de Lagemaat LN; Morgan M; Giles P; Sas Z; Gonzalez MV; Lawson H; Paris J; Edwards-Hicks J; Schaak K; Subramani C; Gezer D; Armesilla-Diaz A; Wills J; Easterbrook A; Coman D; So CW; O'Carroll D; Vernimmen D; Rodrigues NP; Pollard PJ; Morton NM; Finch A; Kranc KR
J Exp Med; 2017 Mar; 214(3):719-735. PubMed ID: 28202494
[TBL] [Abstract][Full Text] [Related]
14. Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients.
Aasebø E; Forthun RB; Berven F; Selheim F; Hernandez-Valladares M
Curr Pharm Biotechnol; 2016; 17(1):52-70. PubMed ID: 26306748
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-26a-5p and microRNA-23b-3p up-regulate peroxiredoxin III in acute myeloid leukemia.
Jiang W; Min J; Sui X; Qian Y; Liu Y; Liu Z; Zhou H; Li X; Gong Y
Leuk Lymphoma; 2015 Feb; 56(2):460-71. PubMed ID: 24828865
[TBL] [Abstract][Full Text] [Related]
16. The use of molecular genetics to refine prognosis in acute myeloid leukemia.
Bhatnagar B; Garzon R
Curr Hematol Malig Rep; 2014 Jun; 9(2):148-57. PubMed ID: 24659319
[TBL] [Abstract][Full Text] [Related]
17. Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner.
Braoudaki M; Lambrou GI; Vougas K; Karamolegou K; Tsangaris GT; Tzortzatou-Stathopoulou F
J Hematol Oncol; 2013 Jul; 6():52. PubMed ID: 23849470
[TBL] [Abstract][Full Text] [Related]
18. Comparative proteomics in acute myeloid leukemia.
Luczak M; Kaźmierczak M; Hadschuh L; Lewandowski K; Komarnicki M; Figlerowicz M
Contemp Oncol (Pozn); 2012; 16(2):95-103. PubMed ID: 23788862
[TBL] [Abstract][Full Text] [Related]
19. The tumor suppressor annexin A10 is a novel component of nuclear paraspeckles.
Quiskamp N; Poeter M; Raabe CA; Hohenester UM; König S; Gerke V; Rescher U
Cell Mol Life Sci; 2014 Jan; 71(2):311-29. PubMed ID: 23715859
[TBL] [Abstract][Full Text] [Related]
20. Three are better than one: plasminogen receptors as cancer theranostic targets.
Ceruti P; Principe M; Capello M; Cappello P; Novelli F
Exp Hematol Oncol; 2013 Apr; 2(1):12. PubMed ID: 23594883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
